Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL

~4 mi. (Grenoble, France, +96 more cities)

Centre Hospitalier Universitaire de Grenoble

Diffuse Large B-Cell Lymphoma, +1 more condition

brentuximab vedotin, +2 more drugs

chemotherapy, +1 more type

A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer

~4 mi. (Grenoble, France, +87 more cities)

Hopital Albert Michallon

ALK Fusion

Non-Small Cell Lung Carcinoma

brigatinib

targeted therapy

A Study of Brentuximab Vedotin and CHP in Frontline Treatment of PTCL With Less Than 10% CD30 Expression

~5 mi. (La Tronche, France, +31 more cities)

Centre Hospitalier Universitaire de Grenoble

TNFRSF8 Deficient Expression

Adult T-Cell Leukemia/Lymphoma, +8 more conditions

brentuximab vedotin, +3 more drugs

chemotherapy, +2 more types

Efficacy, Safety, and Tolerability of V937 Administered Intravenously or Intratumorally With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone in Participants With Advanced/Metastatic Melanoma (V937-011)

~5 mi. (La Tronche, France, +25 more cities)

CHU de Grenoble Hopital Nord ( Site 2027)

Melanoma

coxsackievirus A21, +1 more drug

immunotherapy

Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)

~59 mi. (Valence, France, +137 more cities)

Centre Hospitalier de Valence-Service de Dermatologie ( Site 0377)

Skin Squamous Cell Carcinoma

pembrolizumab

immunotherapy

FOLFOX + Panitumumab According to a "Stop and go" Strategy With a Reintroduction Loop After Progression on Fluoropyrimidine as Maintenance Treatment, as the First Line in Patients With Metastatic Colorectal Adenocarcinoma Without a RAS Mutation

~67 mi. (Sainte-Colombe, France, +41 more cities)

Clinique Trenel

Colorectal Adenocarcinoma

fluorouracil, +3 more drugs

chemotherapy, +2 more types

Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

~77 mi. (Metz-Tessy, France, +158 more cities)

Centre Hospitalier Annecy Genevois ( Site 0811)

Non-Small Cell Lung Carcinoma

olaparib, +4 more drugs

chemotherapy, +3 more types

Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) Plus Chemotherapy in Participants With Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-7902-015/E7080-G000-321/LEAP-015)

~77 mi. (Metz-Tessy, France, +131 more cities)

Centre Hospitalier Annecy Genevois ( Site 1117)

HER2 Negative

Adenocarcinoma of the Gastroesophageal Junction, +2 more conditions

CAPOX regimen, +3 more drugs

chemotherapy, +2 more types

TAK-788 as First-line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations

~77 mi. (Bron, France, +144 more cities)

Hopital Louis Pradel

EGFR Exon 20 Insertion

Non-Squamous Non-Small Cell Lung Carcinoma

mobocertinib

targeted therapy

A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)

~79 mi. (Pierre-Bénite, France, +144 more cities)

CH Lyon Sud Hospices Civils de Lyon ( Site 1203)

Clear Cell Renal Cell Carcinoma

belzutifan, +3 more drugs

immunotherapy, +1 more type

Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)

~79 mi. (Pierre-Bénite, France, +176 more cities)

Centre Hospitalier Lyon Sud ( Site 2064)

Endometrial Carcinoma, +1 more condition

chemotherapy, +2 more drugs

chemotherapy, +2 more types

Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

~79 mi. (Pierre-Bénite, France, +226 more cities)

C.H.U. Lyon Sud ( Site 0436)

Prostate Adenocarcinoma

enzalutamide, +1 more drug

hormone therapy, +1 more type